[go: up one dir, main page]

DE69003652D1 - Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen. - Google Patents

Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.

Info

Publication number
DE69003652D1
DE69003652D1 DE90906552T DE69003652T DE69003652D1 DE 69003652 D1 DE69003652 D1 DE 69003652D1 DE 90906552 T DE90906552 T DE 90906552T DE 69003652 T DE69003652 T DE 69003652T DE 69003652 D1 DE69003652 D1 DE 69003652D1
Authority
DE
Germany
Prior art keywords
aliphatic alcohols
inflammatory
treatment
skin diseases
viral skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90906552T
Other languages
English (en)
Other versions
DE69003652T2 (de
Inventor
David Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Engelhard Arzneimittel GmbH and Co KG
Original Assignee
LIDAK PHARMACEUTICALS LA JOLLA
Avanir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIDAK PHARMACEUTICALS LA JOLLA, Avanir Pharmaceuticals Inc filed Critical LIDAK PHARMACEUTICALS LA JOLLA
Publication of DE69003652D1 publication Critical patent/DE69003652D1/de
Application granted granted Critical
Publication of DE69003652T2 publication Critical patent/DE69003652T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DE90906552T 1989-04-28 1990-04-16 Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen. Expired - Lifetime DE69003652T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment
PCT/US1990/002045 WO1990013216A2 (en) 1989-04-28 1990-04-16 Inflammatory disease treatment

Publications (2)

Publication Number Publication Date
DE69003652D1 true DE69003652D1 (de) 1993-11-04
DE69003652T2 DE69003652T2 (de) 1994-03-24

Family

ID=23353439

Family Applications (2)

Application Number Title Priority Date Filing Date
DE90906552T Expired - Lifetime DE69003652T2 (de) 1989-04-28 1990-04-16 Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
DE122007000080C Active DE122007000080I2 (de) 1989-04-28 1990-04-16 Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE122007000080C Active DE122007000080I2 (de) 1989-04-28 1990-04-16 Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.

Country Status (10)

Country Link
US (1) US4874794A (de)
EP (1) EP0428642B1 (de)
JP (1) JPH03505882A (de)
AT (1) ATE95060T1 (de)
DE (2) DE69003652T2 (de)
DK (1) DK0428642T3 (de)
ES (1) ES2060158T3 (de)
HK (1) HK120497A (de)
NL (1) NL300354I2 (de)
WO (1) WO1990013216A2 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
US5296514A (en) * 1991-04-23 1994-03-22 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5198217A (en) * 1991-09-24 1993-03-30 Choice Pharmaceuticals Topical demulcent for viral and inflammatory diseases of the skin
WO1995016434A1 (en) * 1993-12-13 1995-06-22 Lidak Pharmaceuticals Sucrose ester c-20 to c-28 alcohol formulations
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ES2242582T3 (es) 1999-09-03 2005-11-16 Cabby Business Inc. Procedimiento de alta eficiencia para la preparacion de esteroles de alta pureza.
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
ES2270991T3 (es) * 2000-04-12 2007-04-16 Liplasome Pharma A/S Sistemas basados en lipidos para el direccionado de agentes de diagnostico.
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
EA200400535A1 (ru) * 2001-10-16 2005-06-30 Аванир Фармасютикалз ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
DE10203688A1 (de) 2002-01-31 2003-08-07 Bayer Cropscience Ag Synergistische insektizide Mischungen
DE10207242A1 (de) * 2002-02-21 2003-09-04 Bayer Cropscience Ag Synergistische insektizide Mischungen
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050075407A1 (en) 2003-08-25 2005-04-07 Foamix Ltd. Foam incorporating eutetic mixture
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
AU2006313443A1 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
WO2011112997A1 (en) 2010-03-11 2011-09-15 Chemic Laboratories, Inc. Novel compositions and methods
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
WO2017029647A1 (en) 2015-08-20 2017-02-23 Meir Eini Tetracycline management of egfr inhibitor associated dermatoses
US11666520B2 (en) 2015-12-28 2023-06-06 Johnson & Johnson Consumer Inc. Hair growth composition and method
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2021022056A1 (en) 2019-07-31 2021-02-04 Foamix Pharmaceuticals Ltd. Compositions and methods and uses thereof
TW202135825A (zh) 2019-12-31 2021-10-01 美商維恩治療股份有限公司 含托法替尼（Ｔｏｆａｃｉｔｉｎｉｂ）之基於彈性體的無水凝膠調配物

Also Published As

Publication number Publication date
ES2060158T3 (es) 1994-11-16
NL300354I1 (nl) 2008-08-01
US4874794A (en) 1989-10-17
DE122007000080I2 (de) 2008-11-06
EP0428642B1 (de) 1993-09-29
DK0428642T3 (da) 1994-02-21
NL300354I2 (nl) 2008-10-01
JPH03505882A (ja) 1991-12-19
HK120497A (en) 1997-09-05
ATE95060T1 (de) 1993-10-15
DE122007000080I1 (de) 2008-02-28
DE69003652T2 (de) 1994-03-24
EP0428642A1 (de) 1991-05-29
WO1990013216A2 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
DE3752045D1 (de) Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
ATE56366T1 (de) Verband fuer die behandlung von wunden und herstellungsverfahren.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3588023D1 (de) Mittel zur Behandlung von Herzerkrankungen.
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
ATE106754T1 (de) Verfahren zur herstellung von rinder-pericard- materialien und ihre verwendung.
JPS6423842A (en) Method for allowing pulmonary respiration animal to be slaughtered to swoon
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
DK137589D0 (da) Salicylsyreholdigt middel til behandling af hudsygdomme
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE69004425D1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
DE59002154D1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
ATE56363T1 (de) Verfahren zur herstellung von keimabgetoeteten oder in ihrer virulenz abgeschwaechten substanzen sowie deren verwendung.
DE3170699D1 (en) Method for the preparation of transplants with higher biological stability
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
ATE79881T1 (de) Herstellung und verwendung eines reaktionsprodukts aus ascorbinsaeure mit alpha,beta-ungesaettigtem keton oder vinylaliphatischem keton.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ATE19181T1 (de) Verfahren zur herstellung von eiweisskonzentraten mit fester bis gelartiger konsistenz aus tierischem blut und/oder blutplasma.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810

Spc suppl protection certif: 12 2007 000 080

Filing date: 20071121

8327 Change in the person/name/address of the patent owner

Owner name: AVANIR PHARMACEUTICALS CORPORATION, LA JOLLA, , US

V484 Delivery of the decision of grant

Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810

Spc suppl protection certif: 12 2007 000 080

Filing date: 20071121

V457 Spc granted

Free format text: PRODUCT NAME: DOCOSAN-1-OL; REGISTRATION NO/DATE: 67648.00.00, 20070810

Spc suppl protection certif: 12 2007 000 080

Filing date: 20071121

R081 Change of applicant/patentee

Owner name: ENGELHARD ARZNEIMITTEL GMBH & CO. KG, DE

Free format text: FORMER OWNER: AVANIR PHARMACEUTICALS, ALISO VIEJO, US

Spc suppl protection certif: 122007000080

Filing date: 20071121

Expiry date: 20100417

Extension date: 20150416

R082 Change of representative

Free format text: PRODUCT NAME: DOCOSAN-1-OL; NAT. REGISTRATION NO/DATE: 67648.00.00 20070810; FIRST REGISTRATION: SE18517 20031114

Spc suppl protection certif: 122007000080

Filing date: 20071121

Expiry date: 20100417

Representative=s name: WITTE, WELLER & PARTNER PATENTANWAELTE MBB, DE

Extension date: 20150416

R071 Expiry of right

Free format text: PRODUCT NAME: DOCOSAN-1-OL; NAT. REGISTRATION NO/DATE: 67648.00.00 20070810; FIRST REGISTRATION: SE18517 20031114

Spc suppl protection certif: 122007000080

Filing date: 20071121

Expiry date: 20100417

Extension date: 20150416

Effective date: 20150417